American Geriatrics Society 2019 Beers Criteria Update

Slideshow

The American Geriatrics Society released the 2019 updates to the Beers Criteria. What are the key takeaways for primary care physicians? Scroll through our slideshow to find out.

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
Clinically Validated Blood Test Identifies Preeclampsia Risk Early in Pregnancy, New Study Shows / Image credit: ©interstid/AdobeStock

Clinically Validated Blood Test Identifies Preeclampsia Risk Early in Pregnancy, New Study Shows

Sydney Jennings
May 2nd 2025
Article

A simple RNA-based blood test can identify the risk of hypertensive disorders in pregnancy months before symptoms appear, researchers reported.

Breakthroughs in Atopic Dermatitis with Linda Stein Gold, MD: Primary Viewpoints Podcast

Breakthroughs in Atopic Dermatitis with Linda Stein Gold, MD: Primary Viewpoints Podcast

Linda Stein Gold, MD;Sydney Jennings
March 9th 2025
Podcast

“I think it’s important to have a lot of tools in our toolbox, and [tapinarof cream 1%] is one that gives us great flexibility," said Linda Stein Gold, MD.

Adolescent Hyperglycemia, Insulin Resistance Drive Early Cardiac Structural Changes / image credit Andrew Agbaje, MD, MPH, PhD Courtesy of University of Eastern Finland

Adolescent Hyperglycemia, Insulin Resistance Drive Early Cardiac Structural Changes, Novel Cohort Study Finds

Grace Halsey
May 2nd 2025
Article

Persistent hyperglycemia between ages 17 and 24 tripled the risk of left ventricular hypertrophy and did so 5 times faster among young women, a new study found.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Dupilumab Approved for Uncontrolled Chronic Spontaneous Urticaria: Daily Dose / image credit: ©New Africa/AdobeStock

Dupilumab Approved for Uncontrolled Chronic Spontaneous Urticaria: Daily Dose

Sydney Jennings
May 2nd 2025
Article

Your daily dose of the clinical news you may have missed.

New Data on Dupilumab Reinforces Its Impact on Chronic Respiratory Diseases

New Data on Dupilumab Reinforces Its Impact on Chronic Respiratory Diseases

Sydney Jennings
May 1st 2025
Article

New clinical trial findings to be presented at ATS 2025 highlights the effectiveness of dupilumab in treating COPD and asthma.

© 2025 MJH Life Sciences

All rights reserved.